|
PFE's Operating Income Growth by Quarter and Year
Pfizer Inc's Operating Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
Operating Income Growth Y/Y▼
|
Operating Income Growth Y/Y▼
|
| PFE Operating Income (in millions $) |
FY 2020 |
FY 2019 |
FY 2018 |
FY 2017 |
| IV Quarter |
December |
341.00
|
1,535.00
|
2,312.00
|
3,231.00
|
| III Quarter |
September |
3,324.00
|
11,045.00
|
3,764.00
|
1,617.00
|
| II Quarter |
June |
3,091.00
|
4,266.00
|
3,976.00
|
3,021.00
|
| I Quarter |
March |
4,105.00
|
4,414.00
|
3,949.00
|
3,477.00
|
| FY |
|
10,861.00
|
21,260.00
|
14,001.00
|
11,346.00
|
| PFE Operating Income forth quarter 2020 Y/Y Growth Comment |
Pfizer Inc reported drop in Operating Income in the forth quarter by -77.79% to $ 341.00 millions, from the same quarter in 2019.
The fall in the forth quarter Pfizer Inc's Operating Income compares unfavorably to the Company's average Operating Income decrease of -0.76%.
Looking into forth quarter results within Major Pharmaceutical Preparations industry 26 other companies have achieved higher Operating Income growth. While Pfizer Inc' s Operating Income meltdown of -77.79% ranks overall at the positon no. 1109 in the forth quarter.
Explain Operating Income growth
|
| PFE Operating Income ( Y/Y Growth %) |
2020
|
2019 |
2018 |
2017 |
| IV Quarter |
December |
-77.79 % |
-33.61 % |
-28.44 % |
-16.96 % |
| III Quarter |
September |
-69.9 % |
193.44 % |
132.78 % |
-11.83 % |
| II Quarter |
June |
-27.54 % |
7.29 % |
31.61 % |
-10.04 % |
| I Quarter |
March |
-7 % |
11.78 % |
13.57 % |
-3.28 % |
| FY |
|
-48.91 % |
51.85 % |
23.4 % |
-10.51 % |
PFE Operating Income (Quarter on Quarter Growth %) |
2020
|
2019 |
2018 |
2017 |
| IV Quarter |
December |
-89.74 % |
-86.1 % |
-38.58 % |
99.81 % |
| III Quarter |
September |
7.54 % |
158.91 % |
-5.33 % |
-46.47 % |
| II Quarter |
June |
-24.7 % |
-3.35 % |
0.68 % |
-13.11 % |
| I Quarter |
March |
167.43 % |
90.92 % |
22.22 % |
-10.64 % |
| FY (Year on Year) |
|
-48.91 % |
51.85 % |
23.4 % |
-10.51 % |
| Operating Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 49.34 % |
-0.76 % |
-49.17 % |
| (Sep 29 2019) |
|
(Sep. 30, 2015) |
|
|
| Operating Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 49.34 % |
-0.76 % |
-49.17 % |
| (Sep 29 2019) |
|
(Sep. 30, 2015) |
|
| Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020 |
Pfizer Inc's Q/Q Operating Income Growth
| Operating Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 79375 % |
1263.57 % |
-99.9 % |
| (March 31, 2010) |
|
|
| PFE's IV. Quarter Q/Q Operating Income Comment |
In the IV. Quarter 2020 Pfizer Inc realized fall in Operating Income sequentially by -89.74% to $ 341.00 millions, from $ 3,324.00 millions declared a quarter before.
But that's not important issue, as Pfizer Inc's Operating Income always seem to dip in the IV. Quarter.
Within Major Pharmaceutical Preparations industry 39 other companies have achieved higher Operating Income quarter on quarter growth. While Pfizer Inc's Operating Income growth quarter on quarter, overall rank is 2102. |
|
|
|
| Operating Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 79375 % |
1263.57 % |
-99.9 % |
| (March 31, 2010) |
|
|
| PFE's IV. Quarter Q/Q Operating Income Comment |
In the IV. Quarter 2020 Pfizer Inc disclosed fall in Operating Income from the third quarter by -89.74% to $ 341.00 millions, from $ 3,324.00 millions achived a quarter before.
As we evaluate present slump at the IV. Quarter, we should take into consideration, that commonly IV. Quarter 2020 results occur weaker then in the preciding period, Laura Álvarez, a business researcher mentioned.
Within Major Pharmaceutical Preparations industry 39 other companies have achieved higher Operating Income quarter on quarter growth. While Pfizer Inc's Operating Income growth quarter on quarter, overall rank is 2102. |
|
Pfizer Inc's 12 Months Operating Income Growth Year on Year
Operating Income TTM Growth |
12 Months Ending
(Dec 31 2020) |
12 Months Ending
(Sep 27 2020) |
12 Months Ending
(Jun 28 2020) |
12 Months Ending
(Mar 29 2020) |
12 Months Ending
(Dec 31 2019) |
| Cumulative Operating Income 12 Months Ending |
$ 8,166.00 |
$ 12,055.00 |
$ 19,776.00 |
$ 20,951.00 |
$ 21,260.00 |
| Y / Y Operating Income Growth (TTM) |
-61.59 % |
-45.3 % |
34.02 % |
44.83 % |
51.85 % |
| Year on Year Operating Income Growth Overall
Ranking |
# 1815 |
# 1650 |
# 408 |
# 330 |
# 234 |
| Seqeuential Operating Income Change (TTM) |
-32.26 % |
-39.04 % |
-5.61 % |
-1.45 % |
-3.53 % |
| Seq. Operating Income Growth (TTM) Overall
Ranking |
# 1109 |
# 1513 |
# 1293 |
# 1017 |
# 1189 |
| Cumulative Operating Income growth
Comment |
Pfizer Inc's cumulative 12 months Operating Income continue to drop, but on the faster rate at -61.59% year on year, at Dec 31 2020 compare to the -45.3% decrease at Sep 27 2020. If the Pfizer Inc's fiscal year would end at Dec 31 2020, annual Operating Income would be $8,166 millions.
In the Healthcare sector 135 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 1650 to 1815. |
| Operating Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
49.34 % |
-0.76 % |
-49.17 % |
|
|
|
|
|
| Operating Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
52.51 % |
3.49 % |
-61.59 % |
|
|
|
| Operating Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 27 |
| Sector |
# 97 |
| S&P 500 |
# 1109 |
|
| Cumulative Operating Income growth
Comment |
Pfizer Inc's cumulative 12 months Operating Income continue to drop, but on the faster rate at -61.59% year on year, at Dec 31 2020 compare to the -45.3% decrease at Sep 27 2020. If the Pfizer Inc's fiscal year would end at Dec 31 2020, annual Operating Income would be $8,166 millions.
In the Healthcare sector 135 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 1650 to 1815. |
| Operating Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
49.34 % |
-0.76 % |
-49.17 % |
|
|
|
| Operating Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
52.51 % |
3.49 % |
-61.59 % |
|
|
|
| Operating Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 27 |
| Sector |
# 97 |
| S&P 500 |
# 1109 |
|
